Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating devices for treating epilepsy.

Brian Litt1

  • 1Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. littb@mail.med.upenn.edu

Epilepsia
|August 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual Responsive Neurostimulation Implantation: From Intracranial Connectivity to Optimized Lead Placement.

medRxiv : the preprint server for health sciences·2026
Same author

Cortical stimulation reveals effective disconnection of the epileptogenic network at seizure onset.

Epilepsia·2026
Same author

Association between Interictal Spike Rate and Seizure Frequency in a Large Epilepsy Cohort.

medRxiv : the preprint server for health sciences·2026
Same author

The seizure embedding map: A spatio-temporal transformer for comparing patients by ictal intracranial EEG features at scale.

Journal of neural engineering·2026
Same author

Regional excitability, not epileptic pathology, drives stimulation-evoked interictal spike increases.

medRxiv : the preprint server for health sciences·2026
Same author

How Much Does the Reduced EEG Montage Matter for Seizure Detection?: A Large-Cohort Simulation Study.

medRxiv : the preprint server for health sciences·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

New implantable devices show promise for epilepsy treatment. Careful clinical trials are essential for their evaluation and integration into patient care, offering alternatives to surgery or multiple medications.

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Medical Device Development

Background:

  • Epilepsy treatment research is advancing with new implantable devices.
  • Pilot studies indicate promising safety and efficacy for these devices.
  • Understanding regulatory pathways is crucial for device integration.

Purpose of the Study:

  • To explore challenges in clinical trials for implantable epilepsy devices.
  • To compare device approval processes with antiepileptic drugs (AEDs).
  • To determine the future role of these technologies in epilepsy management.

Main Methods:

  • Review of implantable device literature, focusing on trial limitations.
  • Analysis of Food and Drug Administration (FDA) approval processes.

Related Experiment Videos

  • Case study of the vagal nerve stimulator for epilepsy.

    • Main Results:

    • Implantable devices offer hope for patients with treatment-resistant epilepsy.
    • These devices could serve as alternatives to surgery or polypharmacy.
    • Successful integration depends on rigorous clinical evaluation.

    Conclusions:

    • Carefully designed clinical trials are vital for antiepileptic device acceptance.
    • Unique device characteristics, including surgical implantation, require specific trial considerations.
    • Navigating FDA approval is a critical step for new epilepsy technologies.